476 related articles for article (PubMed ID: 16915118)
1. Procalcitonin increase in early identification of critically ill patients at high risk of mortality.
Jensen JU; Heslet L; Jensen TH; Espersen K; Steffensen P; Tvede M
Crit Care Med; 2006 Oct; 34(10):2596-602. PubMed ID: 16915118
[TBL] [Abstract][Full Text] [Related]
2. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial.
Jensen JU; Hein L; Lundgren B; Bestle MH; Mohr TT; Andersen MH; Thornberg KJ; Løken J; Steensen M; Fox Z; Tousi H; Søe-Jensen P; Lauritsen AØ; Strange D; Petersen PL; Reiter N; Hestad S; Thormar K; Fjeldborg P; Larsen KM; Drenck NE; Ostergaard C; Kjær J; Grarup J; Lundgren JD;
Crit Care Med; 2011 Sep; 39(9):2048-58. PubMed ID: 21572328
[TBL] [Abstract][Full Text] [Related]
3. Serum procalcitonin in children with suspected sepsis: a comparison with C-reactive protein and neutrophil count.
Casado-Flores J; Blanco-Quirós A; Asensio J; Arranz E; Garrote JA; Nieto M
Pediatr Crit Care Med; 2003 Apr; 4(2):190-5. PubMed ID: 12749651
[TBL] [Abstract][Full Text] [Related]
4. The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer*.
Debiane L; Hachem RY; Al Wohoush I; Shomali W; Bahu RR; Jiang Y; Chaftari AM; Jabbour J; Al Shuaibi M; Hanania A; Pravinkumar SE; Schuetz P; Raad I
Crit Care Med; 2014 Dec; 42(12):2500-7. PubMed ID: 25083975
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic efficacy and prognostic value of serum procalcitonin concentration in patients with suspected sepsis.
Ruiz-Alvarez MJ; García-Valdecasas S; De Pablo R; Sanchez García M; Coca C; Groeneveld TW; Roos A; Daha MR; Arribas I
J Intensive Care Med; 2009; 24(1):63-71. PubMed ID: 19054806
[TBL] [Abstract][Full Text] [Related]
6. Let's go dynamic with procalcitonin!
Molnár Z; Bogár L
Crit Care Med; 2006 Oct; 34(10):2687-8. PubMed ID: 16983272
[No Abstract] [Full Text] [Related]
7. [Prognostic value of procalcitonin, C-reactive protein and leukocytes in septic shock].
Suberviola B; Castellanos-Ortega A; González-Castro A; García-Astudillo LA; Fernández-Miret B
Med Intensiva; 2012 Apr; 36(3):177-84. PubMed ID: 22055776
[TBL] [Abstract][Full Text] [Related]
8. Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis.
Castelli GP; Pognani C; Cita M; Stuani A; Sgarbi L; Paladini R
Minerva Anestesiol; 2006; 72(1-2):69-80. PubMed ID: 16407808
[TBL] [Abstract][Full Text] [Related]
9. Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis.
Dahaba AA; Hagara B; Fall A; Rehak PH; List WF; Metzler H
Br J Anaesth; 2006 Oct; 97(4):503-8. PubMed ID: 16849384
[TBL] [Abstract][Full Text] [Related]
10. Eosinopenia: Is it a good marker of sepsis in comparison to procalcitonin and C-reactive protein levels for patients admitted to a critical care unit in an urban hospital?
Shaaban H; Daniel S; Sison R; Slim J; Perez G
J Crit Care; 2010 Dec; 25(4):570-5. PubMed ID: 20435431
[TBL] [Abstract][Full Text] [Related]
11. The Procalcitonin And Survival Study (PASS) - a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients.
Jensen JU; Lundgren B; Hein L; Mohr T; Petersen PL; Andersen LH; Lauritsen AO; Hougaard S; Mantoni T; Bømler B; Thornberg KJ; Thormar K; Løken J; Steensen M; Carl P; Petersen JA; Tousi H; Søe-Jensen P; Bestle M; Hestad S; Andersen MH; Fjeldborg P; Larsen KM; Rossau C; Thomsen CB; Ostergaard C; Kjaer J; Grarup J; Lundgren JD
BMC Infect Dis; 2008 Jul; 8():91. PubMed ID: 18620598
[TBL] [Abstract][Full Text] [Related]
12. Procalcitonin and C-reactive protein as markers of bacterial infection in critically ill children at onset of systemic inflammatory response syndrome.
Simon L; Saint-Louis P; Amre DK; Lacroix J; Gauvin F
Pediatr Crit Care Med; 2008 Jul; 9(4):407-13. PubMed ID: 18496408
[TBL] [Abstract][Full Text] [Related]
13. Procalcitonin as a prognostic marker for sepsis: a prospective observational study.
Jain S; Sinha S; Sharma SK; Samantaray JC; Aggrawal P; Vikram NK; Biswas A; Sood S; Goel M; Das M; Vishnubhatla S; Khan N
BMC Res Notes; 2014 Jul; 7():458. PubMed ID: 25034373
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis.
Pettilä V; Hynninen M; Takkunen O; Kuusela P; Valtonen M
Intensive Care Med; 2002 Sep; 28(9):1220-5. PubMed ID: 12209268
[TBL] [Abstract][Full Text] [Related]
15. Procalcitonin as a prognostic factor in severe acute exacerbation of chronic obstructive pulmonary disease.
Rammaert B; Verdier N; Cavestri B; Nseir S
Respirology; 2009 Sep; 14(7):969-74. PubMed ID: 19659517
[TBL] [Abstract][Full Text] [Related]
16. Procalcitonin levels are lower in intensive care unit patients with H1N1 influenza A virus pneumonia than in those with community-acquired bacterial pneumonia. A pilot study.
Piacentini E; Sánchez B; Arauzo V; Calbo E; Cuchi E; Nava JM
J Crit Care; 2011 Apr; 26(2):201-5. PubMed ID: 20813489
[TBL] [Abstract][Full Text] [Related]
17. Changes in circulating procalcitonin versus C-reactive protein in predicting evolution of infectious disease in febrile, critically ill patients.
Hoeboer SH; Groeneveld AB
PLoS One; 2013; 8(6):e65564. PubMed ID: 23762396
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia.
Ramírez P; Ferrer M; Martí V; Reyes S; Martínez R; Menéndez R; Ewig S; Torres A
Crit Care Med; 2011 Oct; 39(10):2211-7. PubMed ID: 21705887
[TBL] [Abstract][Full Text] [Related]
19. Comparison of procalcitonin and C-reactive protein as markers of sepsis.
Luzzani A; Polati E; Dorizzi R; Rungatscher A; Pavan R; Merlini A
Crit Care Med; 2003 Jun; 31(6):1737-41. PubMed ID: 12794413
[TBL] [Abstract][Full Text] [Related]
20. Procalcitonin is persistently increased among children with poor outcome from bacterial sepsis.
Han YY; Doughty LA; Kofos D; Sasser H; Carcillo JA
Pediatr Crit Care Med; 2003 Jan; 4(1):21-5. PubMed ID: 12656537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
